- About Us
- Contact Us
- Registrar Resources
- Reports & Factsheets
- Data & Mapping Tool
- Cancer Patient Notification Information
- California Department of Public Health
- Chronic Disease Surveillance and Research Branch
- California Behavioral Risk Factor Surveillance System
- Meaningful Use of Electronic Health Records
- Reports, Factsheets and CCR Brochures
- Acknowledgement and Disclaimer
- Patient Record Request Form
- Patient Record Request Check List
Web Query Tool
Generate customized maps and tables of California cancer incidence or mortality rates.
Quick Links for More Information on Meaningful Use
- CMS Website
- CDC Meaningful Use F.A.Q
- Meaningful Use Resources to Get Started
- Electronic Health Record (EHR) Incentive Program FAQs
Meaningful Use : Cancer Reporting in California
The California Department of Public Health (CDPH) is coordinating all reporting for Meaningful Use (MU) for California. CDPH is utilizing a Health Information Exchange (HIE) Gateway to receive and process MU files. For more information on the CDPH HIE Gateway, please go to http://hie.cdph.ca.gov.
To participate in MU for Cancer Reporting providers cancer data must meet the HL7 Clinical Document Architecture (CDA) 2.0 standard, and the messages must conform to the CDA implementation specifications found in the Implementation Guide for Ambulatory Healthcare Provider Reporting to Central Cancer Registries. and the technology used by the providers to generate the HL7 CDA .XML message has to be listed on the Certified Health IT Product List (CHPL) for cancer data reporting.
There are two transmission options for submitting MU data for Cancer Reporting:
- File Upload via Hypertext Transfer Protocol Secure (HTTPS) – CCR
- Secure File Transfer Protocol (SFTP)
If you do not know your transport method, please ask your information technology representative or your Electronic Health Record (EHR) vendor prior to enrolling to submit MU cancer data.
Instructions for Enrolling in MU Cancer Reporting
Open the following URL in your web browser:
Follow the on-screen directions to Create a New Account and Click Create Account.
A "Thank you" screen will appear that references the email mentioned below.
You will receive an email from HIEHelp@cdph.ca.gov, similar to the image below, requesting confirmation of your registration.
Click on the link in the email to confirm your registration.
Enroll for Cancer Reporting
You will be redirected to the Log In page.
The screen below is then displayed:
At a minimum, please complete the required fields marked with an asterisk and then Click Submit.
You are then directed to the Manage Submissions page:
On the Manage Submissions screen, Click Enroll for the California Cancer Registry.
You are then directed to the CCR Supplemental Data page. Answer the questions and Click Submit.
The following screen appears:
Next, you will receive an email from CDPH HIE Gateway, letting you know that you have successfully enrolled with CCR and providing you directions and options for transmitting your data.
Now that you are Registered and Enrolled with the CDPH HIE Gateway, you are ready to make the decision how you want to submit your MU cancer data. There are two options available to you that will allow the data to go directly to the CCR.
Hypertext Transfer Protocol Secure (HTTPS): Go to https://transfer.ccr.ca.gov/ and follow the directions provided. (This is the easiest and preferred transmission message.)
Secure File Transfer Protocol (SFTP): Click here for instructions here
Once you have selected your transmission option, you are able to submit HL7 CDA .XML files to the Cancer Registry. For the Testing & Validation phase, you are asked to submit 5 test messages that pass the CDC Validation process. Once your office has achieved this, you will then be moved to Production for ongoing data submission.
Ongoing Data Submission
You can begin ongoing data submission in compliance with MU for Cancer Reporting. While actively engaged in the steps above, you will be receiving emails and possibly telephone calls from CDPH HIE and CCR. You should maintain copies of these communications for EHR Incentive Program audit purposes.
If you have any questions regarding these processes, you can contact our office at MU2CCRHelp@ccr.ca.gov
Cancer Reporting Requirements:
Dermatologists are required by law to report all new cases of melanoma to their regional cancer registry.
Please Note: This reporting requirement is separate from the Medicare Physician Quality Reporting System (PQRS), and is mandated by California Health and Safety Code, Section 103885 and California Code of Regulations, Section 2593. These laws require that all cases of melanoma be reported to CCR when diagnosed by a health care provider, laboratory, or hospital. Required reporting enables California to identify disease trends, track disease outbreaks, and aid in preventive measures.
To report new cases of melanoma use the following form:
Below are the MU2 requirements for skin cancers. This information is in California’s Volume I., Section II.1.4 – II.1.4.1-II.1.4.2
Reportable Skin Cancers Include:
- Skin cancers in the genital sites (any histology) (vagina (C52.9); clitoris (C51.2); labium (C51.0); vulva (C51.9); prepuce (C60.0); penis (C60.9) and scrotum (C63.2) are reportable.
- Malignant tumors of the skin such as
- adnexal carcinomas (e.g., carcinomas of the sweat gland,
- sebaceous gland,
- ceruminous gland, and hair follicle,
- melanomas including the following
- Early melanoma insitu*
- Evolving melanoma insitu*
- Merkel cell tumors
- Any carcinoma arising in a hemorrhoid is reportable since hemorrhoids arise in mucosa, not in the skin.
Non-Reportable to the Cancer Registry:
- Basal cell carcinomas of the skin
- Epithelial carcinomas of the skin
- Papillary carcinomas of the skin
- Squamous cell carcinomas of the skin
- Early Melanoma
- Evolving Melanoma
NOTE: The term “insitu” must be included in diagnosis in order for early and evolving melanoma insitu to be reportable
- EHR Incentive Program MU Stage1 Requirements Overview [PDF, 1MB]
- Stage 1 Eligible Professional Meaningful Use Table of Contents [PDF, 114KB]
- EP Attestation Worksheet [PDF, 365KB]
- Hospital Attestation Worksheet [PDF, 345KB]
- CAH Payment Tip Sheet [PDF, 188KB
Stage 2 Overview and Measures
Stage 2 Regulations
- Stage 2 Overview Tipsheet
- Stage 2 Guide for Eligible Professionals
- Stage 2 Meaningful Use Specification Sheet Table of Contents for Eligible Professionals
- Stage 2 Meaningful Use Specification Sheet Table of Contents for Eligible Hospitals and CAHs
- Stage 2 Data Sharing Tipsheet for Eligible Professionals
- Security Risk Analysis Tipsheet for Eligible Professionals
- Stage 2 Worksheet for Eligible Professionals
- Stage 2 Worksheet for Eligible Hospitals
- Patient Electronic Access Tipsheet
- Clinical Decision Support Tipsheet
- Public Health Registry Tipsheet
- Stage 2 Meaningful Use Final Rule
- 2014 Standards and Certification Final Rule
- Stage 2 Correction Notice
Office of the National Coordinator of Health IT (ONC) EHR Resources
- Provider User Guide for NIST EHR Randomizer Tool
- Stage 1 Reference Grid: Stage 1 meaningful use objectives for 2014 Certified EHR Technology and correlated certification criteria and standards
- Stage 2 Reference Grid: Stage 2 meaningful use objectives for 2014 Certified EHR Technology and correlated certification criteria and standards